- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07615244
STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)
The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.
Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.
This is a monocentric, national study including two patient cohorts:
Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.
Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.
Participants will:
- Undergo clinical evaluation, including internal medicine and neurological assessments
- Provide blood and urine samples for laboratory analyses
- Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
- Receive psychological/neuropsychological evaluations
- Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)
Studieoversigt
Status
Betingelser
Intervention / Behandling
- Diagnostisk test: Factor VIII (FVIII)
- Diagnostisk test: Von Willebrand factor (VWF) antigen
- Diagnostisk test: VWF:RCo
- Diagnostisk test: VWF-propeptide
- Diagnostisk test: VWF multimers
- Diagnostisk test: sP-selectin
- Diagnostisk test: sCD40L
- Diagnostisk test: F1+2
- Diagnostisk test: VEGF-A
- Diagnostisk test: VCAM
- Diagnostisk test: ICAM
- Diagnostisk test: IL-1β
- Diagnostisk test: IL-6
- Diagnostisk test: PTX3
- Diagnostisk test: BlyS
- Diagnostisk test: Neutrophil elastase and myeloperoxidase (NETs) markers
- Diagnostisk test: soluble C5b-9
- Diagnostisk test: C5a
- Diagnostisk test: NFL
- Diagnostisk test: GFAP
- Genetisk: Whole exome sequencing - WES
- Diagnostisk test: Proteomic Analysis
- Diagnostisk test: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
- Diagnostisk test: Microfluidic Flow Chamber
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Milano
-
Milan, Milano, Italien, 20122
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- aged ≥18 years
- with a confirmed diagnosis of TTP (either congenital or acquired immune-mediated TTP)
- referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) in acute phase of a first or recurrent episode (cohort 1) or referred at our outpatient clinic (S.C. Medicina - Emostasi e Trombosi) during clinical remission at more than 3 months from the clinical response of the previous episode (cohort 2). In any case, patient enrolment will always take place in the S.C. Medicina - Emostasi e Trombosi
- providing a signed informed consent
Exclusion Criteria:
- Patients who do not possess the above inclusion criteria or have known contraindications to the instrumental exam included in the study (MRI).
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
|
Andet: Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Prevalence
Tidsramme: From enrollment to the last visit (after 36 months from T0)
|
Prevalence of microcirculation damage in iTTP patients compared to general population
|
From enrollment to the last visit (after 36 months from T0)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Cerebral microcirculation lesions
Tidsramme: From enrollment to the last visit (after 36 months from T0)
|
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
|
From enrollment to the last visit (after 36 months from T0)
|
|
Retinal microcirculation changes
Tidsramme: From enrollment to the last visit (after 36 months from T0)
|
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
|
From enrollment to the last visit (after 36 months from T0)
|
|
Peripheral microcirculation
Tidsramme: From enrollment to the last visit (after 36 months from T0)
|
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
|
From enrollment to the last visit (after 36 months from T0)
|
|
Association between cerebral MRI lesions and cognitive or psychological symptoms
Tidsramme: From enrollment to the last visit (36 months from T0)
|
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
|
From enrollment to the last visit (36 months from T0)
|
|
Modification of preclinical biomarkers
Tidsramme: From enrollment to the last visit (36 months from T0)
|
Explore the modification of preclinical biomarkers over time at different stage of the disease
|
From enrollment to the last visit (36 months from T0)
|
|
Associations between preclinical biomarkers and microcirculatory damage
Tidsramme: From enrollment to the last visit (36 months from T0)
|
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
|
From enrollment to the last visit (36 months from T0)
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Cytopeni
- Patologiske processer
- Blødning
- Hudmanifestationer
- Hæmatologiske sygdomme
- Blodkoagulationsforstyrrelser
- Blodpladeforstyrrelser
- Trombotiske mikroangiopatier
- Purpura, trombocytopenisk
- Purpura
- Trombocytopeni
- Trombofili
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Hemiske og lymfatiske sygdomme
- Purpura, trombotisk trombocytopenisk
- Undersøgelsesteknikker
- Genetiske teknikker
- Sekvensanalyse
- Sekvensanalyse, DNA
- Hele genomsekventering
- Exome -sekventering
Andre undersøgelses-id-numre
- IRCCSMaggioreH (IRCCSMaggioreH)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med TTP - Trombotisk trombocytopenisk purpura
-
TakedaIkke rekrutterer endnu
-
TakedaIkke rekrutterer endnuTrombotisk trombocytopenisk purpura (TTP)
-
Turkish Hematology AssociationSanofiRekrutteringTTP - Trombotisk trombocytopenisk purpuraKalkun
-
TakedaGodkendt til markedsføringTrombotisk trombocytopenisk purpura (TTP)
-
BloodworksUniversity of WashingtonAfsluttetPurpura, trombotisk trombocytopenisk | TTPForenede Stater
-
The First Affiliated Hospital of Soochow UniversityRekruttering
-
University College, LondonRekrutteringTTP - Trombotisk trombocytopenisk purpuraDet Forenede Kongerige
-
University College, LondonAfsluttetTrombotisk trombocytopenisk purpura (TTP)Det Forenede Kongerige
-
Fondazione Luigi VillaRekruttering
-
Baxalta now part of ShireAfsluttetArvelig trombotisk trombocytopenisk purpura (TTP)Forenede Stater, Tyskland, Det Forenede Kongerige, Schweiz, Østrig, Japan, Polen
Kliniske forsøg med Factor VIII (FVIII)
-
Hoffmann-La RocheRekrutteringVon Willebrands sygdom, type 3Forenede Stater, Canada, Belgien, Spanien, Tyskland, Japan, Holland, Det Forenede Kongerige, Frankrig, Polen, Sydafrika, Italien, Colombia, Sverige
-
BayerAfsluttetHæmofili AForenede Stater
-
Baxalta now part of ShireAfsluttet
-
Hoffmann-La RocheChugai PharmaceuticalAfsluttetHæmofili AAustralien, Taiwan, Korea, Republikken, Frankrig, Tyskland, Italien, Sydafrika, Spanien, Forenede Stater, Japan, Irland, Polen, Det Forenede Kongerige, Costa Rica
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlAfsluttetHæmofili AForenede Stater, Indien, Spanien, Argentina, Østrig, Brasilien, Chile, Egypten, Iran, Islamisk Republik, Italien, Mexico, Saudi Arabien, Sydafrika, Kalkun
-
Hospices Civils de LyonAfsluttet
-
Dhaka Medical CollegeIkke rekrutterer endnu
-
Hoffmann-La RocheRekrutteringVon Willebrands sygdom, type 3Forenede Stater, Canada, Belgien, Spanien, Tyskland, Holland, Det Forenede Kongerige, Frankrig, Japan, Sydafrika, Italien, Colombia, Polen, Sverige
-
Chulalongkorn UniversityAfsluttet